Ask Warren

Telcon RF Pharmaceutical

200230 · KOSDAQ · ₩200230 · 텔콘RF제약

₩2,025▼ ₩55 (2.64%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩29B₩9.7B₩13B₩9.8B₩10B₩10B₩14B₩7.2B
Cost of sales₩16B₩8B₩8.8B₩7.4B₩8.1B₩8.6B₩7.8B₩6.3B
Gross profit₩13B₩1.7B₩4.5B₩2.4B₩1.9B₩1.4B₩6B₩853M
Operating income−₩806M−₩1.4B₩2.6B−₩8.7M−₩397M−₩1.5B₩3.1B−₩1.2B
Net income−₩11B−₩11B−₩6.6B−₩3B₩13B−₩15B−₩30B₩13B
Net income to shareholders−₩11B−₩11B₩9.9B−₩4.9B−₩1.8B−₩15B−₩12B₩3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩187B₩150B₩157B₩157B₩134B₩140B₩154B₩153B
Current assets₩72B₩64B₩58B₩53B₩21B₩25B₩26B₩18B
Cash and equivalents₩17B₩8B₩26B₩34B₩2.9B₩2.6B₩3.3B₩6.4B
Total liabilities₩88B₩53B₩48B₩55B₩68B₩71B₩70B₩57B
Current liabilities₩80B₩51B₩46B₩53B₩67B₩71B₩70B₩57B
Borrowings₩58B₩38B₩32B₩32B₩48B₩56B₩55B₩42B
Total equity₩99B₩97B₩109B₩102B₩66B₩69B₩83B₩96B
Shareholders' equity₩73B₩97B₩109B₩102B₩65B₩68B₩83B₩95B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.6B−₩1.6B₩1.4B₩419M₩702M−₩822M−₩455M−₩399M
Capital spending₩1.4B₩276M₩114M₩19M₩115M₩71M₩826M₩1.9B
Free cash flow₩230M−₩1.8B₩1.3B₩400M₩587M−₩893M−₩1.3B−₩2.3B

Consolidated where available. Amounts in won.

Also known as: Telcon RF Pharmaceutical / 텔콘RF제약 / 200230 / KRX:200230

Source: KRX statistical information